NIH-funded research NIH-funded research

Detecting and tracking Alzheimer's disease using electrochemical sensors

Official title: Electrochemical sensors for the detection and tracking of Alzheimer’s disease

Funded at University of Delaware · NIH-11018379 · Data updated 2026-11-12

This study is working on creating new sensors that can easily and accurately check for signs of Alzheimer's disease in your blood, helping to catch it early and manage it better.

More s Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Delaware
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startJune 1, 2025
Project endFebruary 28, 2030
Funding year2025
Award (this year)$235,260
NIH project number1P20GM156674-01
Project IDNIH-11018379 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals at risk for Alzheimer's disease or those experiencing early symptoms of dementia.

Less likely to help

Patients with advanced Alzheimer's disease or those who do not exhibit any symptoms of cognitive decline may not benefit from this research.

What this research studies

This research focuses on developing advanced electrochemical sensors to detect and monitor Alzheimer's disease (AD) biomarkers in blood or plasma. The goal is to create organic electrochemical transistors (OECTs) that can provide sensitive and specific measurements of Amyloid-β, a key biomarker for AD. By improving the detection methods, the research aims to facilitate early diagnosis and continuous monitoring of the disease, which is crucial for timely therapeutic interventions. Patients may benefit from more accessible and cost-effective testing options that can help manage their condition more effectively.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection and better management of Alzheimer's disease, improving patients' quality of life.

How similar studies have gone: Other research has shown promise in using biosensors for detecting biomarkers in various conditions, suggesting that this approach could be effective for Alzheimer's disease as well.

Where this research is happening

  • University of Delaware
    Newark, United States
    Active

Researchers

  • Principal investigator: Kayser, Laure V. — University of Delaware
  • Study coordinator: Kayser, Laure V.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.